TRD-UP (n = 100) | BP (n = 94) | Statistics | |
---|---|---|---|
Age (Years) (Mean ± SD) | 46.5 ± 13.3 | 40.6 ± 14.3 | t = 2.97, p = 0.003 |
Ratio of Males: Females | 41:59 | 37:57 | χ2 = 0.05, p = 0.816 |
Patients≤65 years of age | 90 (90%) | 91 (96%) | χ2 = 3.59, p = 0.058 |
Marital status | 41 (41%) | 15 (16%) | χ2 = 14.79, p < 0.001 |
Unemployed/Disability sick leave | 74 (74%) | 62 (66%) | χ2 = 1.49, p = 0.221 |
Age of first major depressive episode (Mean ± SD) | 37.7 ± 15.3 | 26.4 ± 9.8 | t = 6.14, p < 0.001 |
Early onset of major depressive episodes(< 25) | 29 (29%) | 52 (55%) | χ2 = 13.80, p < 0.001 |
Age of first psychiatric consultation (Mean ± SD) | 35.9 ± 15.2 | 24.9 ± 10.7 | t = 5.83, p < 0.001 |
Age of first psychiatric hospitalization (Mean ± SD) | 40.1 ± 15.0 | 29.4 ± 11.7 | t = 4.15, p < 0.001 |
Patients with recurrent depression (> 3) | 39 (39%) | 47 (50%) | χ2 = 2.37, p = 0.123 |
Duration of illness-current episode (years) (Mean ± SD) | 11.9 ± 11.5 | 15.4 ± 12.1 | t = −2.08, p = 0.039 |
Patients with comorbid substance use | 27 (27%) | 32 (34%) | χ2 = 1.14, p = 0.287 |
History of Alcohol use | 9 (9%) | 16 (17%) | χ2 = 2.77, p = 0.096 |
History of Cannabis use | 6 (6%) | 19 (20%) | χ2 = 8.71, p = 0.003 |
History of Cocaine use | 3 (3%) | 3 (3%) | χ2 = 0.006, p = 0.939 |
Number of Failed pharmacotherapies (Mean ± SD) | 3.6 ± 2.6 | 5.3 ± 2.7 | t = −4.31, p < 0.001 |
Failed antidepressant trials (Mean ± SD) | 2.25 ± 1.8 | 1.63 ± 1.4 | t = 2.63, p = 0.009 |
Failed SGA (Mean ± SD) | 0.65 ± 0.7 | 1.68 ± 1.2 | t = −7.17, p < 0.001 |
Failed Mood stabilizers (Mean ± SD) | 0.3 ± 0.6 | 1.3 ± 0.9 | t = −8.55, p < 0.001 |
Patients currently having psychotherapy | 41 (41%) | 78 (83%) | χ2 = 36.01, p < 0.001 |
Number of hospitalizations for depression since 1st episode | |||
None | 56 (56%) | 15 (16%) | χ2 = 33.48, p < 0.001 |
> one | 20 (20%) | 60 (64%) | χ2 = 38.41, p < 0.001 |
Patients with 1st degree relative with affective illness | 51 (51%) | 63 (67%) | χ2 = 5.13, p = 0.023 |
Patients with Anxiety disorders | 61 (61%) | 22 (23%) | χ2 = 27.97, p < 0.001 |
Patients with Panic disorders | 19 (19%) | 3 (3%) | χ2 = 12.04, p < 0.001 |
Patients with Melancholic symptoms | 74 (74%) | 40 (42%) | χ2 = 19.77, p < 0.001 |
Patients with Atypical symptoms | 14 (14%) | 25 (26%) | χ2 = 4.78, p = 0.029 |
Patients with suicidal attempts | 23 (23%) | 42 (44%) | χ2 = 10.22, p = 0.001 |
History of MDE with psychotic symptoms | 27 (24%) | 59 (63%) | χ2 = 25.11, p < 0.001 |
Patients with Personality disorders (Axis II in DSM-IV) | 44 (44%) | 45 (48%) | χ2 = 0.29, p = 0.589 |
Cluster A | 7 (7%) | 1 (1%) | χ2 = 4.31, p = 0.038 |
Cluster B | 19 (19%) | 16(17%) | χ2 = 0.128, p = 0.720 |
Cluster C | 25 (25%) | 5 (5%) | χ2 = 14.36, p < 0.001 |
Patients with Medical condition potentially relevant to treatment (Axis III in DSM-IV) | |||
Autoimmune diseases | 11 (11%) | 2 (2%) | χ2 = 6.101, p = 0.014 |
Cardiovascular diseases | 25 (25%) | 18 (19%) | χ2 = 0.962, p = 0.327 |
Chronic pain disorders | 25 (25%) | 15 (16%) | χ2 = 2.421, p = 0.120 |
Neurological conditions | 13 (13%) | 5 (5%) | χ2 = 3.396, p = 0.065 |
Metabolic disorder | 10 (10%) | 15 (16%) | χ2 = 1.532, p = 0.216 |